Anbio Biotechnology Class A
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Anbio Biotechnology Class A 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NNNN
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products.
CEOMichael Lau
CEOMichael Lau
Employees27
Employees27
HeadquartersFrankfurt, Hessen
HeadquartersFrankfurt, Hessen
Founded2021
Founded2021
Employees27
Employees27
NNNN Key Statistics
Market cap4.16B
Market cap4.16B
Price-Earnings ratio525.12
Price-Earnings ratio525.12
Dividend yield—
Dividend yield—
Average volume37.96K
Average volume37.96K
High today$34.27
High today$34.27
Low today$26.89
Low today$26.89
Open price$34.27
Open price$34.27
Volume28.74K
Volume28.74K
52 Week high$55.65
52 Week high$55.65
52 Week low$5.00
52 Week low$5.00
Stock Snapshot
Anbio Biotechnology Class A(NNNN) stock is priced at $29.21, giving the company a market capitalization of 4.16B. It carries a P/E multiple of 525.12.
On 2025-12-12, Anbio Biotechnology Class A(NNNN) stock moved within a range of $26.89 to $34.27. With shares now at $29.21, the stock is trading +8.6% above its intraday low and -14.8% below the session's peak.
Trading activity shows a volume of 28.74K, compared to an average daily volume of 37.96K.
Over the past 52 weeks, Anbio Biotechnology Class A(NNNN) stock has traded between a high of $55.65 and a low of $5.00.
Over the past 52 weeks, Anbio Biotechnology Class A(NNNN) stock has traded between a high of $55.65 and a low of $5.00.
People also own
Based on the portfolios of people who own NNNN. This list is generated using Robinhood data, and it’s not a recommendation.